EXECUTIVE EMPLOYMENT AGREEMENT for Tobin SchilkeExecutive Employment Agreement • February 28th, 2019 • Revance Therapeutics, Inc. • Pharmaceutical preparations • California
This Executive Employment Agreement (the “Agreement”), made between Revance Therapeutics, Inc. (the “Company”) and Tobin Schilke (“Executive”) (collectively, the “Parties”), is effective as of November 5, 2018 (the “Start Date”).
LICENSE AGREEMENT BY AND BETWEEN REVANCE THERAPEUTICS, INC. AND SHANGHAI FOSUN PHARMACEUTICAL INDUSTRIAL DEVELOPMENT CO., LTD. DECEMBER 4, 2018License Agreement • February 28th, 2019 • Revance Therapeutics, Inc. • Pharmaceutical preparations • New York
This License Agreement (the “Agreement”) is entered into as of December 4, 2018 (the “Effective Date”) by and between Revance Therapeutics, Inc., a Delaware corporation with a place of business at 7555 Gateway Blvd., Newark, California, 94560 (“Revance”) and Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd., a Chinese corporation with a place of business at Building A, 1289 Yishan Road, Minhang District, Shanghai 200233, China (“Fosun”). Revance and Fosun are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
